Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy

References

• World Health Organization. Diabetes. Factsheet n° 312. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/ [Last accessed 2 March 2015]
   Google Scholar
• Nielsen AB, Gannik D, Siersma V, Olivarius NF. The relationship between HbA1c level, symptoms and self-rated health in type 2 diabetic patients. Scand J Prim Health Care 2011;29:157-64
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes – 2013. Diabetes Care 2013;36(Suppl 1):S11-66
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. Global Guideline for Type 2 Diabetes. Available at: http://www.idf.org/global-guideline-type-2-diabetes-2012 [Last accessed 2 March 2015]
   Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-79
   PubMed Web of Science ®Google Scholar
• Kolotkin RL, Head S, Brookhart A. Construct validity of the Impact of Weight on Quality of Life Questionnaire. Obes Res 1997;5:434-41
   PubMedGoogle Scholar
• Kolotkin RL, Crosby RD, Kosloski KD, Williams GR. Development of a brief measure to assess quality of life in obesity. Obes Res 2001;9:102-11
   PubMedGoogle Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
   PubMed Web of Science ®Google Scholar
• Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-43
   PubMed Web of Science ®Google Scholar
• Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In: Bradley C, editor. Handbook of Psychology and Diabetes. Chur: Harwood Academic Publishers, 1994:111-32
   Google Scholar
• Bharmal M, Payne K, Atkinson MJ, et al. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes 2009;7:36
   PubMed Web of Science ®Google Scholar
• Brod M, Hammer M, Christensen T, et al. Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM–Diabetes and TRIM–Diabetes Device). Health Qual Life Outcomes 2009;7:83
   PubMed Web of Science ®Google Scholar
• Garcia-Perez LE, Alvarez M, Dilla T, et al. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 2013;4:175-94
   PubMed Web of Science ®Google Scholar
• Grandy S, Fox KM, Bazata DD. Health-related quality of life association with weight change in type 2 diabetes mellitus: perception vs. reality. Int J Clin Pract 2013;67:455-61
   PubMed Web of Science ®Google Scholar
• Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract 2010;87:204-10
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf [Last accessed 2 March 2015]
   Google Scholar
• Nunnally JC, Bernstein IH. Psychometric Theory, 3rd edn. New York: McGraw-Hill Inc., 1994
   Google Scholar
• Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334
   Web of Science ®Google Scholar
• Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann 1979;2:197-207
   PubMedGoogle Scholar
• Batko JJ. The intraclass coefficient as a measure of reliability. Psychological Rep 1966;19:3-11
   PubMed Web of Science ®Google Scholar
• Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991;12:142-58
   PubMedGoogle Scholar
• Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 1973;33:613-19
   Web of Science ®Google Scholar
• Hays RD, Anderson R, Revicki D. Assessing Reliability and Validity of Measurement in Clinical Trials. Quality of Life Assessment in Clinical Trials: Methods and Practice. Oxford, UK: Oxford University Press, 1998:169-82
   Google Scholar
• Fitzpatrick R, Fletcher A, Gore S, et al. Quality of life measures in health care. I: Applications and issues in assessment. BMJ 1992;305:1074-7
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1977
   Google Scholar
• Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987;40:171-8
   PubMedGoogle Scholar
• Guyatt GH, Deyo RA, Charlson M, et al. Responsiveness and validity in health status measurements: a clarification. J Clin Epidemiol 1989;42:403-8
   PubMed Web of Science ®Google Scholar
• Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27(3 Suppl):178-89
   PubMed Web of Science ®Google Scholar
• Bradley C, Todd C, Gorton T, et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999;8(1–2):79-91
   PubMed Web of Science ®Google Scholar
• Wee HL, Tan CE, Goh SY, Li SC. Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian country. Pharmacoeconomics 2006;24:673-82
   PubMed Web of Science ®Google Scholar
• Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Med Care 1997;35:440-53
   Google Scholar
• Meadows K, Steen N, McColl E, et al. The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients – development and psychometric evaluation. Qual Life Res 1996;5:242-54
   PubMed Web of Science ®Google Scholar
• Meadows KA, Abrams C, Sandbaek A. Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison. Diabet Med 2000;17:572-80
   PubMed Web of Science ®Google Scholar
• Hammond GS, Aoki TT. Measurement of health status in diabetic patients. Diabetes impact measurement scales. Diabetes Care 1992;15:469-77
   PubMed Web of Science ®Google Scholar
• Wang LS, Sun ZQ, Cai TS, Zhou ZG. Development and evaluation of quality of life scale for patients with type 2 diabetes mellitus. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005;30:21-7
   PubMedGoogle Scholar
• Kotsanos JG, Vignati L, Huster W, et al. Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy. Diabetes Care 1997;20:948-58
   PubMed Web of Science ®Google Scholar
• Shen W, Kotsanos JG, Huster WJ, et al. Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire. Med Care 1999;37(4 Suppl Lilly):AS45-66
   Google Scholar
• Jacobson AM, Barofsky P, Cleary P, et al. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988;11:725-32
   PubMed Web of Science ®Google Scholar
• Jacobson AM, DCCT Research Group. The Diabetes Quality of Life Measure. In: Bradley C, editor. Handbook of Psychology and Diabetes. Chur: Harwood Academic Publishers, 1994:65-87
   Google Scholar
• Jacobson AM, de GM, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994;17:267-74
   PubMed Web of Science ®Google Scholar
• Lundkvist J, Berne C, Bolinder B, Jonsson L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ 2005;6:197-202
   PubMedGoogle Scholar
• Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabetic Med 1994;11:253-61
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66
   PubMed Web of Science ®Google Scholar
• Kolotkin RL, Head S, Hamilton M, Tse CK. Assessing impact of weight on quality of life. Obes Res 1995;3:49-56
   PubMedGoogle Scholar
• Kolotkin RL, Crosby RD. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample. Qual Life Res 2002;11:157-71
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208
   PubMed Web of Science ®Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72
   PubMed Web of Science ®Google Scholar
• De Charro F, Rabin R. EQ-5D from the EuroQol group: an update. Quality of Life Newsletter 2000;25:6-7
   Google Scholar
• Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998;316:736-41
   PubMed Web of Science ®Google Scholar
• Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 1995;7:490-502
   PubMed Web of Science ®Google Scholar
• Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 2002;40:113-28
   PubMed Web of Science ®Google Scholar
• Feeny DH, Torrance GW, Furlong WJ. Health utilities index. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven Press, 1996:239-52
   Google Scholar
• Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001;33:375-84
   PubMed Web of Science ®Google Scholar
• Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:54
   PubMedGoogle Scholar
• Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995;7:503-20
   PubMed Web of Science ®Google Scholar
• Torrance GW, Feeny DH, Furlong WJ, et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care 1996;34:702-22
   PubMed Web of Science ®Google Scholar
• Hunt SM, McKenna SP, McEwen J, et al. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med 1981;15(3 Pt 1):221-9
   Web of Science ®Google Scholar
• Hunt SM. Nottingham Health Profile. In: Wenger NK, Mattson ME, Furberg CD, Elinson J, editors. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq Publishing, 1984:165-69
   Google Scholar
• Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. Br J Gen Pract 1985;35:185-8
   Web of Science ®Google Scholar
• Dupuy HJ. The Psychological General Well-Being Index (PGWBI). In: Wenger NK, Mattson ME, Furberg CD, Elinson J, editors. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq Publishing Inc., 1984:170-83
   Google Scholar
• Gaston JE, Vogl L. Psychometric properties of the general well-being index. Qual Life Res 2005;14:71-5
   PubMed Web of Science ®Google Scholar
• Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217-27
   PubMedGoogle Scholar
• Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med 2001;33:350-7
   PubMed Web of Science ®Google Scholar
• Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33
   PubMed Web of Science ®Google Scholar
• Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724-35
   Google Scholar
• Ware JEJ, Sherbourne CD, Davies AR. Developing and testing the MOS 20-item Short-Form Health Survey: a general population application. In: Stewart AL, Ware JE, editors. Measuring Functioning and Well-Being. The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992:277-90
   Google Scholar
• Bradley C. The well-being questionnaire. In: Bradley C, editor. Handbook of Psychology and Diabetes. Chur: Harwood Academic Publishers, 1994:89-109
   Google Scholar
• Bradley C. The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability. Diabetes Care 2000;23:875
   PubMed Web of Science ®Google Scholar
• Mitchell J, Bradley C. Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease. Qual Life Res 2001;10:465-73
   PubMed Web of Science ®Google Scholar
• Speight J, Bradley C. The W-BQ28 measure of generic and diabetes-specific well-being is shown to be reliable and sensitive to change in DIABQOL+ and DAFNE studies. Diabetic Med 2002;19(Suppl 2):10
   PubMedGoogle Scholar
• Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003;12:85-91
   PubMed Web of Science ®Google Scholar
• Bech P. Measuring the dimension of Psychological General Well-Being by the WHO-5. Quality of Life Newsletter 2004;32:15-16
   Google Scholar
• Bech P. Male depression: stress and aggression as pathways to major depression. In: Dawson A, Tylee A, editors. Depression: Social and Economic Timebomb. London: BMJ Books, 2001:63-6
   Google Scholar
• Henkel V, Mergl R, Kohnen R, et al. Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ 2003;326:200-1
   PubMed Web of Science ®Google Scholar
• The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:551-8
   PubMed Web of Science ®Google Scholar
• Bode BW, Testa MA, Magwire M, et al. Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes. Diabetes Obes Metabol 2010;12:604-12
   PubMed Web of Science ®Google Scholar
• Bradley C. Diabetes Clinic Satisfaction Questionnaire (DCSQ). In: Bradley C, editor. Handbook of Psychology and Diabetes. Newark, NJ: Hardwood Academic Publishers, 1994:392-3
   Google Scholar
• Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006;15:481-91
   PubMed Web of Science ®Google Scholar
• Peyrot M, Harshaw Q, Shillington AC, et al. Validation of a tool to assess medication treatment satisfaction in patients with type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ). Diabet Med 2012;29:1060-6
   PubMed Web of Science ®Google Scholar
• Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabetic Med 1990;7:445-51
   PubMed Web of Science ®Google Scholar
• Ishii HO. Reproducibility and validity of a satisfaction questionnaire on hypoglycemic agents: The Oral Hypoglycemic Agent Questionnaire (OHA-Q). Diabetology International 2012;3:152-63
   Google Scholar
• Monahan PO, Lane KA, Hayes RP, et al. Reliability and validity of an instrument for assessing patients' perceptions about medications for diabetes: the PAM-D. Qual Life Res 2009;18:941-52
   PubMed Web of Science ®Google Scholar
• Donatti C, Wild D, Horblyuk R, et al. Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS). Diabetes Res Clin Pract 2008;80:108-13
   PubMed Web of Science ®Google Scholar
• Brod M, Christensen T, Hammer M, et al. Examining the ability to detect change using the TRIM–Diabetes and TRIM–Diabetes Device measures. Qual Life Res 2011;20:1513-18
   PubMed Web of Science ®Google Scholar
• Tirgoviste CI, Strachinariu R, Farcasiu E, et al. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study. Rom J Intern Med 2003;41:153-62
   PubMedGoogle Scholar
• Attkisson CC, Greenfield TK. The UCSF Client Satisfaction Scales: I. The Client Satisfaction Questionnaire-8. In: Maruish ME, editor. The use of psychological testing for treatment planning and outcomes assessment, 3rd edn. Mahwah, NJ, USA: Lawrence Erlbaum Associates, 2004:799-811
   Google Scholar
• Nguyen TD, Attkisson CC, Stegner BL. Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann 1983;6:299-313
   PubMedGoogle Scholar
• Greenfield TK, Attkisson CC. The UCSF Client Satisfaction Questionnaire Scales: II. The Service Satisfaction Scale-30. In: Maruish ME, editor. The use of psychological testing for treatment planning and outcomes assessment, 3rd edn. Mahwah, NJ, USA: Lawrence Erlbaum Associates, 2004:813-37
   Google Scholar
• Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann 1982;5:233-7
   PubMedGoogle Scholar
• Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004;2:12
   PubMedGoogle Scholar
• Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 2005;8(Suppl 1):S9-24
   PubMed Web of Science ®Google Scholar
• Ostini R, Dower J, Donald M. The Audit of Diabetes-Dependent Quality of Life 19 (ADDQoL): feasibility, reliability and validity in a population-based sample of Australian adults. Qual Life Res 2012;21:1471-7
   PubMed Web of Science ®Google Scholar
• Soon SS, Goh SY, Bee YM, et al. Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] questionnaire: reliability and validity among Singaporeans with type 2 diabetes mellitus. Appl Health Econ Health Policy. 2010;8:239-49
   PubMedGoogle Scholar
• Kamarul IM, Ismail AA, Naing L, Wan Mohamad WB. The reliability and validity of the Malay version of the 18-item audit of Diabetes Dependent Quality of Life (the Malay ADDQOL) questionnaire. Southeast Asian J Trop Med Public Health 2007;38:398-405
   PubMedGoogle Scholar
• Costa FA, Guerreiro JP, Duggan C. An Audit of Diabetes-Dependent Quality of Life (ADDQoL) for Portugal: exploring validity and reliability. Pharmacy Practice 2006;4:123-8
   PubMedGoogle Scholar
• Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002;18(Suppl 3):S64-9
   Google Scholar
• Huang IC, Hwang CC, Wu MY, et al. Diabetes-specific or generic measures for health-related quality of life? Evidence from psychometric validation of the D-39 and SF-36. Value Health 2008;11:450-61
   PubMed Web of Science ®Google Scholar
• Ushakova O, Sokolovskaya V, Morozova A, et al. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in Russia. Clin Ther 2007;29:2374-84
   PubMed Web of Science ®Google Scholar
• Meadows K, Erpelding ML, Fagot-Campagna A, et al. An update on the Diabetes Health Profile (DHP-18) – a short measure of psychological and behavioural dysfunctioning in people with type 1 and type 2 diabetes. Patient-Report Outcomes Newsletter 2008;40:17-18
   Google Scholar
• Li TC, Lin CC, Liu CS, et al. Validation of the Chinese version of the diabetes impact measurement scales amongst people suffering from diabetes. Qual Life Res 2006;15:1613-19
   PubMed Web of Science ®Google Scholar
• Andayani TM. I. The association of diabetes-related factor and quality of life in type 2 diabetes mellitus. Int J Pharm Pharmaceut Sci 2010;2:139-45
   Google Scholar
• Pakpour AH, Saffari M, Burri A. Translation and validation of an Iranian version of the Diabetes Quality of Life measure. J Diabetes Investig 2012;3:471-8
   Google Scholar
• Huang IC, Liu JH, Wu AW, et al. Evaluating the reliability, validity and minimally important difference of the Taiwanese version of the diabetes quality of life (DQOL) measurement. Health Qual Life Outcomes 2008;6:87
   PubMedGoogle Scholar
• Sundaram M, Kavookjian J, Patrick JH. Health-related quality of life and quality of life in type 2 diabetes: relationships in a cross-sectional study. Patient 2009;2:121-33
   PubMedGoogle Scholar
• Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010;8:18
   PubMed Web of Science ®Google Scholar
• Bech P, Moses R, Gomis R. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naive type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res 2003;12:413-25
   PubMed Web of Science ®Google Scholar
• Speight J, Khagram LA, Davies MJ. Generic and diabetes-specific well-being in the AT.LANTUS follow-on study: further psychometric validation of the W-BQ28 indicates its utility in research and clinical practice in type 2 diabetes in the UK. Diabetic Med 2012;29:e345-53
   Google Scholar
• Nicolucci A, Giorgino R, Cucinotta D, et al. Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). Diabetes Nutr Metab 2004;17:235-43
   PubMedGoogle Scholar
• Firestone DN, Jimenez-Briceno L, Reimann JO, et al. Predictors of diabetes-specific knowledge and treatment satisfaction among Costa Ricans. Diabetes Educ 2004;30:281-92
   PubMed Web of Science ®Google Scholar
• Brod M, Christensen T, Kongso JH, Bushnell DM. Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure. J Med Econ 2009;12:309-16
   PubMedGoogle Scholar
• Rubin RX. Development of the Diabetes Medication System Rating Questionnaire- Short Form (DMSRQ-SF) in adults with type 2 diabetes. American Diabetes Association 72nd Scientific Session, 8 June 2012, Philadelphia, PA, USA
   Google Scholar
• Redekop WK, Koopmanschap MA, Stolk RP, et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002;25:458-63
   PubMed Web of Science ®Google Scholar
• Houlden R, Ross S, Harris S, et al. Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of type 2 diabetes: the Canadian INSIGHT Study. Diabetes Res Clin Pract 2007;78:254-8
   PubMed Web of Science ®Google Scholar
• Hayes RP, Meldahl ML. Perceptions About Medications–Diabetes: further revision and validation. International Society for Quality of Life Research (ISOQOL), 28 October 2009, New Orleans, LA, USA
   Google Scholar
• Brohan E, Donatti C, Wild D, et al. The Satisfaction with Oral Antidiabetic Agents Scale (SOADAS): a psychometric validation of a new measure of treatment satisfaction with oral antidiabetic (OAD) medication. American Diabetes Association 66th Scientific Session, 9 June 2006, Washington, DC, USA
   Google Scholar
• Alvarez GF, Tofe PS, Krishnarajah G, et al. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metabol 2008;10(Suppl 1):25-32
   PubMedGoogle Scholar
• Marrett E, Stargardt T, Mavros P, Alexander CM. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain. Diabetes Obes Metabol 2009;11:1138-44
   PubMed Web of Science ®Google Scholar
• Jermendy G, Hungarian RECAP Group, Erdesz D, et al. Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary. Health Qual Life Outcomes 2008;6:88
   PubMedGoogle Scholar
• Benford M, Milligan G, Pike J, et al. Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and compliance. Adv Ther 2012;29:26-40
   PubMed Web of Science ®Google Scholar
• Furlong NJ, Hulme SA, O'Brien SV, et al. Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy. Diabetes Care 2002;25:1685-90
   PubMed Web of Science ®Google Scholar
• Furlong NJ, Hulme SA, O'Brien SV, et al. Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with type 2 diabetes inadequately controlled with oral hypoglycaemic agents. Diabetic Med 2003;20:935-41
   PubMed Web of Science ®Google Scholar
• Douek IF, Allen SE, Ewings P, et al. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial. Diabetic Med 2005;22:634-40
   PubMed Web of Science ®Google Scholar
• Vexiau P, Mavros P, Krishnarajah G, et al. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metabol 2008;10(Suppl 1):16-24
   PubMedGoogle Scholar
• Bergenstal RM, Wysham C, Macconell L, et al. Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. Lancet 2010;376:431-9
   PubMed Web of Science ®Google Scholar
• Best JH, Rubin RR, Peyrot M, et al. Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment. Diabetes Care 2011;34:314-19
   PubMed Web of Science ®Google Scholar
• Alvarez GF, Yin DD, Nocea G, et al. Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study. Health Qual Life Outcomes 2010;8:86
   PubMedGoogle Scholar
• O'Neil PM, Smith SR, Weissman NJ, et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity 2012;20:1426-36
   PubMed Web of Science ®Google Scholar
• Hermansen K, Kolotkin RL, Hammer M, et al. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin. Prim Care Diabetes 2010;4:113-17
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Yale JF, Harris SB, et al. A randomized trial of adding insulin glargine vs. avoidance of insulin in people with type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabetic Med 2006;23:736-42
   PubMed Web of Science ®Google Scholar
• Lingvay I, Legendre JL, Kaloyanova PF, et al. Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better? Diabetes Care 2009;32:1789-95
   PubMed Web of Science ®Google Scholar
• Hu M, Zhou Z, Zeng F, et al. Effects of frequency of follow-up on quality of life of type 2 diabetes patients on oral hypoglycemics. Diabetes Technol Ther 2012;14:777-82
   PubMed Web of Science ®Google Scholar
• Matza LS, Yurgin N, Boye KS, et al. Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change. Curr Med Res Opin 2007;23:2051-62
   PubMed Web of Science ®Google Scholar
• Williams SA, Pollack MF, Dibonaventura M. Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2011;91:363-70
   PubMed Web of Science ®Google Scholar
• Home PD, Bailey CJ, Donaldson J, et al. A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.[Erratum appears in Diabet Med 2010;27:611]. Diabetic Med 2007;24:618-25
   PubMed Web of Science ®Google Scholar
• Aljabri K, Kozak SE, Thompson DM, et al. Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial. Am J Med 2004;116:230-5
   PubMed Web of Science ®Google Scholar
• Charpentier G, Fleury F, Dubroca I, et al. Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes Metab 2005;31:189-95
   PubMed Web of Science ®Google Scholar
• Davies M, Pratley R, Hammer M, et al. Liraglutide improves treatment satisfaction in people with type 2 diabetes compared with sitagliptin, each as an add on to metformin. Diabetic Med 2011;28:333-7
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Goldstein BJ, Vinik AI, et al. Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study. Diabetes Obes Metabol 2006;8:49-57
   PubMed Web of Science ®Google Scholar